Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This is a double-blind placebo-controlled clinical investigation into the efficacy and tolerability of inhaled treprostinil in patients with severe pulmonary arterial hypertension. The primary outcome is the change in 6-minute walk distance from baseline to week 12.
Epistemonikos ID: 92d9510e085b0e9d58bd606c73ad4bf30fcbb41a
First added on: May 04, 2024